Omeros | OMER - DÍVIDA





DÍVIDA Alterar Data
Adma Biologics USD 204.41M 121.28M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Cytokinetics USD 1.29B 4.48M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Immunic USD 0 0 2024-06
Insmed USD 725.8M 1.82M 2026-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
MacroGenics USD 36.51M 500K 2026-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 63.19B 536M 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06